

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 4.91881800 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.22002031 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 4.11380283 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 3.97895592 |
| 5 | actin nucleation (GO:0045010) | 3.96368122 |
| 6 | platelet dense granule organization (GO:0060155) | 3.74654584 |
| 7 | negative regulation of mast cell activation (GO:0033004) | 3.73123557 |
| 8 | cytidine metabolic process (GO:0046087) | 3.64931893 |
| 9 | cytidine catabolic process (GO:0006216) | 3.64931893 |
| 10 | cytidine deamination (GO:0009972) | 3.64931893 |
| 11 | DNA deamination (GO:0045006) | 3.64492427 |
| 12 | sequestering of actin monomers (GO:0042989) | 3.55494933 |
| 13 | eosinophil chemotaxis (GO:0048245) | 3.44686325 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 3.36546440 |
| 15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.36546440 |
| 16 | autophagic vacuole fusion (GO:0000046) | 3.32812363 |
| 17 | neutrophil activation (GO:0042119) | 3.27630453 |
| 18 | B cell mediated immunity (GO:0019724) | 3.16601663 |
| 19 | granulocyte activation (GO:0036230) | 3.12662247 |
| 20 | eosinophil migration (GO:0072677) | 3.09353938 |
| 21 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.07884603 |
| 22 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.03453331 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99496719 |
| 24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.99146007 |
| 25 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97087392 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94958718 |
| 27 | T cell costimulation (GO:0031295) | 2.86847070 |
| 28 | response to interferon-beta (GO:0035456) | 2.84858261 |
| 29 | negative regulation of heart rate (GO:0010459) | 2.84776405 |
| 30 | lymphocyte costimulation (GO:0031294) | 2.84180845 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83411695 |
| 32 | organelle membrane fusion (GO:0090174) | 2.76424785 |
| 33 | xenobiotic catabolic process (GO:0042178) | 2.74492309 |
| 34 | electron transport chain (GO:0022900) | 2.73844638 |
| 35 | respiratory electron transport chain (GO:0022904) | 2.73100469 |
| 36 | hydrogen ion transmembrane transport (GO:1902600) | 2.72168143 |
| 37 | proton transport (GO:0015992) | 2.68532020 |
| 38 | regulation of chronic inflammatory response (GO:0002676) | 2.67522978 |
| 39 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65052106 |
| 40 | hydrogen transport (GO:0006818) | 2.64229775 |
| 41 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.64180945 |
| 42 | mast cell activation (GO:0045576) | 2.59400627 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.58797383 |
| 44 | thrombin receptor signaling pathway (GO:0070493) | 2.58279027 |
| 45 | positive regulation of defense response to virus by host (GO:0002230) | 2.58227040 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57084419 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 2.55111850 |
| 48 | amine catabolic process (GO:0009310) | 2.54142769 |
| 49 | cellular biogenic amine catabolic process (GO:0042402) | 2.54142769 |
| 50 | regulation of mast cell activation (GO:0033003) | 2.53938969 |
| 51 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.53832643 |
| 52 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.50225876 |
| 53 | positive regulation of respiratory burst (GO:0060267) | 2.49623869 |
| 54 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.48170523 |
| 55 | cellular response to interferon-gamma (GO:0071346) | 2.47858125 |
| 56 | phagosome maturation (GO:0090382) | 2.47494812 |
| 57 | cellular response to interferon-beta (GO:0035458) | 2.47401183 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46709174 |
| 59 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.45299917 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 2.44447586 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44243930 |
| 62 | positive regulation of protein homodimerization activity (GO:0090073) | 2.42483936 |
| 63 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.42001304 |
| 64 | adaptation of signaling pathway (GO:0023058) | 2.40774694 |
| 65 | negative regulation of monooxygenase activity (GO:0032769) | 2.40166198 |
| 66 | response to interferon-gamma (GO:0034341) | 2.39573042 |
| 67 | killing of cells of other organism (GO:0031640) | 2.38455706 |
| 68 | disruption of cells of other organism (GO:0044364) | 2.38455706 |
| 69 | arginine metabolic process (GO:0006525) | 2.37989879 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.36392460 |
| 71 | L-fucose catabolic process (GO:0042355) | 2.36361297 |
| 72 | fucose catabolic process (GO:0019317) | 2.36361297 |
| 73 | L-fucose metabolic process (GO:0042354) | 2.36361297 |
| 74 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.34875300 |
| 75 | negative regulation of T cell apoptotic process (GO:0070233) | 2.31883246 |
| 76 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.31360555 |
| 77 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.30656061 |
| 78 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.29115108 |
| 79 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.28567933 |
| 80 | regulation of guanylate cyclase activity (GO:0031282) | 2.28528915 |
| 81 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.28373737 |
| 82 | regulation of cellular extravasation (GO:0002691) | 2.26089653 |
| 83 | behavioral response to nicotine (GO:0035095) | 2.24737829 |
| 84 | sulfation (GO:0051923) | 2.24712560 |
| 85 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.24255106 |
| 86 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.24255106 |
| 87 | leukocyte degranulation (GO:0043299) | 2.24195807 |
| 88 | regulation of mononuclear cell migration (GO:0071675) | 2.24065787 |
| 89 | positive regulation of prostaglandin secretion (GO:0032308) | 2.23925369 |
| 90 | regulation of monocyte chemotaxis (GO:0090025) | 2.23806204 |
| 91 | positive regulation of interleukin-17 production (GO:0032740) | 2.23535788 |
| 92 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.23030952 |
| 93 | positive thymic T cell selection (GO:0045059) | 2.22857402 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.22120068 |
| 95 | cellular response to zinc ion (GO:0071294) | 2.21651112 |
| 96 | positive regulation of T cell apoptotic process (GO:0070234) | 2.20587310 |
| 97 | mitochondrial calcium ion transport (GO:0006851) | 2.16168871 |
| 98 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.16089601 |
| 99 | glutathione biosynthetic process (GO:0006750) | 2.15188952 |
| 100 | leukotriene biosynthetic process (GO:0019370) | 2.15078409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.69097469 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.33837751 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.90498114 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61625507 |
| 5 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.80371888 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61110074 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55371391 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.52017000 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47756804 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42826619 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.00236983 |
| 12 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.92817419 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91511687 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77597916 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73168522 |
| 16 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70473555 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69734295 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68088426 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64930095 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63056593 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61946349 |
| 22 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.55839277 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55206271 |
| 24 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.54425106 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52465439 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51863244 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51764603 |
| 28 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.50515799 |
| 29 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.49294104 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47310893 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47300777 |
| 32 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44166505 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42584672 |
| 34 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.39774215 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37220634 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37202260 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36432703 |
| 38 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.36298748 |
| 39 | AR_20517297_ChIP-Seq_VCAP_Human | 1.33625262 |
| 40 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33236020 |
| 41 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33236020 |
| 42 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.32696972 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32351957 |
| 44 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.30245072 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.27762132 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27358989 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26295638 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25348411 |
| 49 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.24048869 |
| 50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22313140 |
| 51 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21536529 |
| 52 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21512275 |
| 53 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.20305742 |
| 54 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19330120 |
| 55 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18169334 |
| 56 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.17711422 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17056900 |
| 58 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.16566361 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15025233 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15023837 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14946923 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.14710878 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14226363 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13446140 |
| 65 | P300_27268052_Chip-Seq_Bcells_Human | 1.12691154 |
| 66 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12535797 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12535797 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12409958 |
| 69 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12263668 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11293315 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08243238 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.04684149 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04583610 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03972326 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03526367 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02652583 |
| 77 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00754464 |
| 78 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00605588 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00599748 |
| 80 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00365774 |
| 81 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98296124 |
| 82 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.98179719 |
| 83 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98026806 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97891760 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97422920 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96824816 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96099797 |
| 88 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95467206 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94428178 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93312539 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92771451 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91731804 |
| 93 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91326078 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91298621 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90919171 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89697875 |
| 97 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89259280 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88380643 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87681108 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85663402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.60321787 |
| 2 | MP0003724_increased_susceptibility_to | 3.30241261 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.20319651 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.90008593 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.85706481 |
| 6 | MP0009764_decreased_sensitivity_to | 2.68926188 |
| 7 | MP0009785_altered_susceptibility_to | 2.60150899 |
| 8 | MP0004147_increased_porphyrin_level | 2.53365040 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.47799908 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.21146012 |
| 11 | MP0003646_muscle_fatigue | 2.11018890 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.06276586 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.04155175 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.02771852 |
| 15 | MP0001800_abnormal_humoral_immune | 1.97144524 |
| 16 | MP0003436_decreased_susceptibility_to | 1.96831614 |
| 17 | MP0000685_abnormal_immune_system | 1.95543717 |
| 18 | MP0003303_peritoneal_inflammation | 1.94078739 |
| 19 | MP0005387_immune_system_phenotype | 1.91545841 |
| 20 | MP0001790_abnormal_immune_system | 1.91545841 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.91381808 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 1.89401865 |
| 23 | MP0005025_abnormal_response_to | 1.87801919 |
| 24 | MP0002723_abnormal_immune_serum | 1.83540939 |
| 25 | MP0006082_CNS_inflammation | 1.82314412 |
| 26 | MP0005360_urolithiasis | 1.76656301 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.71590427 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.71165110 |
| 29 | MP0009840_abnormal_foam_cell | 1.67579772 |
| 30 | MP0000343_altered_response_to | 1.64481525 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.58838238 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.55879159 |
| 33 | MP0001819_abnormal_immune_cell | 1.54428490 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.53775942 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.53273763 |
| 36 | MP0002419_abnormal_innate_immunity | 1.53016225 |
| 37 | MP0008872_abnormal_physiological_respon | 1.52365909 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49815244 |
| 39 | MP0003075_altered_response_to | 1.46433771 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.43157094 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.42458288 |
| 42 | MP0002102_abnormal_ear_morphology | 1.41060390 |
| 43 | MP0008004_abnormal_stomach_pH | 1.40455362 |
| 44 | MP0005083_abnormal_biliary_tract | 1.36514420 |
| 45 | MP0001905_abnormal_dopamine_level | 1.36337362 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.35880205 |
| 47 | MP0003186_abnormal_redox_activity | 1.32388210 |
| 48 | MP0003866_abnormal_defecation | 1.29931153 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.26587515 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.20779406 |
| 51 | MP0005166_decreased_susceptibility_to | 1.20388912 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.20141827 |
| 53 | MP0008469_abnormal_protein_level | 1.18677798 |
| 54 | MP0003879_abnormal_hair_cell | 1.18415772 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.16062186 |
| 56 | MP0004142_abnormal_muscle_tone | 1.15148548 |
| 57 | MP0003195_calcinosis | 1.15133597 |
| 58 | MP0003638_abnormal_response/metabolism_ | 1.14127434 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.13139360 |
| 60 | MP0001663_abnormal_digestive_system | 1.12909637 |
| 61 | MP0001970_abnormal_pain_threshold | 1.09565832 |
| 62 | MP0005410_abnormal_fertilization | 1.08327246 |
| 63 | MP0000230_abnormal_systemic_arterial | 1.06116288 |
| 64 | MP0005365_abnormal_bile_salt | 1.05449881 |
| 65 | MP0000716_abnormal_immune_system | 1.04772545 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.03710374 |
| 67 | MP0001873_stomach_inflammation | 1.01463581 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.01062884 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 0.98312045 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.97781920 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 0.97677884 |
| 72 | MP0004043_abnormal_pH_regulation | 0.97264857 |
| 73 | MP0003011_delayed_dark_adaptation | 0.97168531 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.96170540 |
| 75 | MP0001542_abnormal_bone_strength | 0.95625408 |
| 76 | MP0004947_skin_inflammation | 0.95502202 |
| 77 | MP0002736_abnormal_nociception_after | 0.94421856 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.91617342 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.91502579 |
| 80 | MP0009763_increased_sensitivity_to | 0.90787596 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 0.88239791 |
| 82 | MP0002405_respiratory_system_inflammati | 0.87687088 |
| 83 | MP0001919_abnormal_reproductive_system | 0.85618797 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.84548542 |
| 85 | MP0002398_abnormal_bone_marrow | 0.84463831 |
| 86 | MP0002429_abnormal_blood_cell | 0.83046119 |
| 87 | MP0005332_abnormal_amino_acid | 0.81128562 |
| 88 | MP0001440_abnormal_grooming_behavior | 0.80358030 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.80304997 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.79648874 |
| 91 | MP0001664_abnormal_digestion | 0.79407190 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.78692419 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.77528173 |
| 94 | MP0005535_abnormal_body_temperature | 0.77379423 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.76829736 |
| 96 | MP0009278_abnormal_bone_marrow | 0.75716318 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.75072726 |
| 98 | MP0002272_abnormal_nervous_system | 0.73984184 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.73574107 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.72954782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47998546 |
| 2 | Decreased central vision (HP:0007663) | 3.91179561 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.60982515 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52099612 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.30734213 |
| 6 | Petechiae (HP:0000967) | 3.24762810 |
| 7 | Increased IgM level (HP:0003496) | 3.19368568 |
| 8 | Stomatitis (HP:0010280) | 3.17135115 |
| 9 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.14842041 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14804785 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14804785 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14804785 |
| 13 | Acute encephalopathy (HP:0006846) | 3.13745102 |
| 14 | IgG deficiency (HP:0004315) | 3.12084915 |
| 15 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.01366642 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.00156010 |
| 17 | Hepatic necrosis (HP:0002605) | 2.99665982 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 2.98096222 |
| 19 | Hepatocellular necrosis (HP:0001404) | 2.93411199 |
| 20 | Increased CSF lactate (HP:0002490) | 2.85436257 |
| 21 | Congenital stationary night blindness (HP:0007642) | 2.85358944 |
| 22 | Generalized aminoaciduria (HP:0002909) | 2.73907761 |
| 23 | Abolished electroretinogram (ERG) (HP:0000550) | 2.72329420 |
| 24 | Purpura (HP:0000979) | 2.70734578 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.66734726 |
| 26 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.66734726 |
| 27 | Nausea (HP:0002018) | 2.65306791 |
| 28 | Hyperalaninemia (HP:0003348) | 2.63818934 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.63818934 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 2.63818934 |
| 31 | Increased muscle lipid content (HP:0009058) | 2.63731288 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 2.62818309 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.59036525 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57721214 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.53257214 |
| 36 | Increased hepatocellular lipid droplets (HP:0006565) | 2.48582382 |
| 37 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.46755948 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43738470 |
| 39 | Glycosuria (HP:0003076) | 2.41632782 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.41632782 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39397916 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38363106 |
| 43 | Obstructive lung disease (HP:0006536) | 2.38363106 |
| 44 | Exertional dyspnea (HP:0002875) | 2.36970371 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.34203208 |
| 46 | Abnormality of magnesium homeostasis (HP:0004921) | 2.33952795 |
| 47 | Agitation (HP:0000713) | 2.31896495 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30773243 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.30219639 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.29058056 |
| 51 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.27870609 |
| 52 | Cerebral edema (HP:0002181) | 2.26573529 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.24411429 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.24411429 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.23918264 |
| 56 | Increased serum ferritin (HP:0003281) | 2.21088934 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.20286338 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 2.17382327 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15999255 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.15585507 |
| 61 | Lactic acidosis (HP:0003128) | 2.14019907 |
| 62 | Polyphagia (HP:0002591) | 2.13464592 |
| 63 | Increased serum lactate (HP:0002151) | 2.09193438 |
| 64 | Optic disc pallor (HP:0000543) | 2.07593115 |
| 65 | Epistaxis (HP:0000421) | 2.06634016 |
| 66 | Hypomagnesemia (HP:0002917) | 2.05751272 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.04605674 |
| 68 | Methylmalonic aciduria (HP:0012120) | 2.03473030 |
| 69 | Lethargy (HP:0001254) | 2.01901232 |
| 70 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01245717 |
| 71 | Abnormality of T cell number (HP:0011839) | 1.98958001 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98232378 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 1.98232378 |
| 74 | B lymphocytopenia (HP:0010976) | 1.97372194 |
| 75 | Vasculitis (HP:0002633) | 1.95912982 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95711729 |
| 77 | Myositis (HP:0100614) | 1.95708366 |
| 78 | Hypoproteinemia (HP:0003075) | 1.92273701 |
| 79 | Encephalitis (HP:0002383) | 1.89806668 |
| 80 | Pancreatic fibrosis (HP:0100732) | 1.86579536 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 1.85964639 |
| 82 | Hydroxyprolinuria (HP:0003080) | 1.81469805 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 1.81469805 |
| 84 | Clumsiness (HP:0002312) | 1.81325164 |
| 85 | Leukocytosis (HP:0001974) | 1.80230843 |
| 86 | Mutism (HP:0002300) | 1.80197279 |
| 87 | Abnormality of serum amino acid levels (HP:0003112) | 1.77252877 |
| 88 | Respiratory failure (HP:0002878) | 1.77051029 |
| 89 | T lymphocytopenia (HP:0005403) | 1.76390304 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75774966 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 1.75774966 |
| 92 | Renal cortical cysts (HP:0000803) | 1.74600385 |
| 93 | Attenuation of retinal blood vessels (HP:0007843) | 1.74454840 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.73188113 |
| 95 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.72467491 |
| 96 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.72467491 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.72464746 |
| 98 | Keratoconus (HP:0000563) | 1.70557792 |
| 99 | Increased corneal curvature (HP:0100692) | 1.70557792 |
| 100 | Pancreatic cysts (HP:0001737) | 1.70473489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.03708346 |
| 2 | TLK1 | 3.31573362 |
| 3 | TXK | 3.03343870 |
| 4 | ADRBK2 | 2.81918248 |
| 5 | KDR | 2.61398568 |
| 6 | MAP4K2 | 2.55111549 |
| 7 | PINK1 | 2.40337753 |
| 8 | BCKDK | 2.30619233 |
| 9 | GRK1 | 2.25492595 |
| 10 | MST4 | 1.94004957 |
| 11 | ZAK | 1.93126251 |
| 12 | TESK2 | 1.90157391 |
| 13 | TIE1 | 1.86442811 |
| 14 | MATK | 1.85597782 |
| 15 | MAP3K12 | 1.83618587 |
| 16 | MAP4K1 | 1.77625599 |
| 17 | IKBKB | 1.74129947 |
| 18 | RIPK4 | 1.72192370 |
| 19 | TEC | 1.69743861 |
| 20 | MYLK | 1.62358125 |
| 21 | ACVR1B | 1.57826780 |
| 22 | SYK | 1.54809051 |
| 23 | BMPR2 | 1.51666865 |
| 24 | GRK7 | 1.50150567 |
| 25 | MAPKAPK3 | 1.47382171 |
| 26 | KIT | 1.40604176 |
| 27 | TBK1 | 1.40458993 |
| 28 | BTK | 1.37884512 |
| 29 | GRK6 | 1.36076446 |
| 30 | EPHB2 | 1.31959224 |
| 31 | MAP3K11 | 1.27341680 |
| 32 | STK16 | 1.25528127 |
| 33 | FES | 1.18362803 |
| 34 | CDK19 | 1.13485311 |
| 35 | DAPK2 | 1.12530907 |
| 36 | PIM2 | 1.10963746 |
| 37 | CSF1R | 1.10772377 |
| 38 | ITK | 1.10165119 |
| 39 | LYN | 1.09602013 |
| 40 | IRAK3 | 1.09206035 |
| 41 | LIMK1 | 1.07046796 |
| 42 | WNK4 | 1.03907202 |
| 43 | ABL2 | 1.03618442 |
| 44 | MAPK13 | 1.01821866 |
| 45 | IKBKE | 1.00165955 |
| 46 | ZAP70 | 0.96898033 |
| 47 | NME2 | 0.96144074 |
| 48 | MAP3K14 | 0.91786156 |
| 49 | DYRK2 | 0.89717630 |
| 50 | NUAK1 | 0.88066352 |
| 51 | MAP2K7 | 0.84506032 |
| 52 | ADRBK1 | 0.82254789 |
| 53 | JAK3 | 0.77388953 |
| 54 | OXSR1 | 0.77247634 |
| 55 | LCK | 0.76048652 |
| 56 | CSK | 0.75571328 |
| 57 | MARK3 | 0.75236201 |
| 58 | PRKCQ | 0.72434191 |
| 59 | TRIM28 | 0.72299544 |
| 60 | PTK2B | 0.71836937 |
| 61 | GRK5 | 0.70342989 |
| 62 | RPS6KA5 | 0.70337359 |
| 63 | TRPM7 | 0.69764183 |
| 64 | DAPK1 | 0.69061057 |
| 65 | SIK3 | 0.68710334 |
| 66 | MAP2K2 | 0.67260134 |
| 67 | ILK | 0.67174499 |
| 68 | DAPK3 | 0.67050721 |
| 69 | FRK | 0.63958319 |
| 70 | PHKG1 | 0.63238355 |
| 71 | PHKG2 | 0.63238355 |
| 72 | CAMKK2 | 0.62004300 |
| 73 | PDK2 | 0.59492931 |
| 74 | ERBB3 | 0.58571824 |
| 75 | BLK | 0.57420528 |
| 76 | PIM1 | 0.57356774 |
| 77 | PRKCA | 0.54801759 |
| 78 | HCK | 0.54419320 |
| 79 | BMPR1B | 0.53545816 |
| 80 | ABL1 | 0.52639892 |
| 81 | TAOK2 | 0.51515543 |
| 82 | PRKG2 | 0.50291649 |
| 83 | TESK1 | 0.49471764 |
| 84 | MINK1 | 0.48349610 |
| 85 | MAP3K5 | 0.47240024 |
| 86 | TYK2 | 0.47217576 |
| 87 | CHUK | 0.45969845 |
| 88 | WNK3 | 0.45856779 |
| 89 | PRKCD | 0.45795458 |
| 90 | PIK3CA | 0.45509503 |
| 91 | PRKCG | 0.44606070 |
| 92 | PRKACA | 0.44281518 |
| 93 | PRKCE | 0.44090443 |
| 94 | PAK1 | 0.43857807 |
| 95 | DDR2 | 0.42158902 |
| 96 | BMX | 0.41967049 |
| 97 | CSNK1G3 | 0.39916029 |
| 98 | PRKACG | 0.39548875 |
| 99 | IGF1R | 0.39239973 |
| 100 | MAP3K4 | 0.37904585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.77930813 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.83444473 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.66320494 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.66263841 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.57518527 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.21457516 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.73909446 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66814559 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50933969 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21485316 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05663906 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03518713 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75538847 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74036809 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70082699 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69295194 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68297177 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.67780715 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67034482 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.60664642 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58890532 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40309243 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38132551 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34619227 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34355847 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32592226 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.24100609 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15004171 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.14094424 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13334628 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.09232636 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08489478 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07196232 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06953157 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.04747886 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.03381530 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.01929011 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95301629 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93687217 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92944094 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 0.91705928 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91481257 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89797200 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89423323 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86819210 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.81978572 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81043749 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78547690 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.72944640 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72808534 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72684804 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72196361 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.71910923 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71650678 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.69318768 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68943221 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66626543 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63335659 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63151405 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62970457 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61232763 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60086805 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59802612 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59665575 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59038445 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55262374 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53281952 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53255659 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51925043 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51431301 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50192388 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49625346 |
| 73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49423210 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.48549001 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48070371 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.47538271 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46565058 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46391704 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.45705701 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45690181 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45129187 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44890150 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43133976 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41622996 |
| 85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41554132 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40540152 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40504685 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.38790893 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38014628 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37023400 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35702833 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34406640 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30983396 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30633656 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28265439 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27197077 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24800893 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22727731 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.21627024 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20416816 |

